890
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Zinc oxide nanoparticles antagonize the effect of Cetuximab on head and neck squamous cell carcinoma in vitro

, , , , , & show all
Pages 513-518 | Received 01 Feb 2017, Accepted 23 Apr 2017, Published online: 23 Jun 2017

Figures & data

Figure 1. Transmission electron microscopy. ZnO-NPs typically clotted together in various intracellular patches of different amounts (indicated by black arrows). Scale bar represents 250 nm, image was taken at 40.000x magnification.

Figure 1. Transmission electron microscopy. ZnO-NPs typically clotted together in various intracellular patches of different amounts (indicated by black arrows). Scale bar represents 250 nm, image was taken at 40.000x magnification.

Figure 2. Immunofluorescence microscopy of the EGF-Receptor. Regular staining of EGFR on the cell membrane without Zn-NPs (A) as well as after addition of Zn-NPs (B), showing no significant difference.

Figure 2. Immunofluorescence microscopy of the EGF-Receptor. Regular staining of EGFR on the cell membrane without Zn-NPs (A) as well as after addition of Zn-NPs (B), showing no significant difference.

Figure 3. MTT-assay for FaDu cell line. Time points were 24 hours (A), 48 hours (B) and 72 hours (C). At 48 and 72 hours, ZnO-NPs increased tumor cell survival at 1 µM Cetuximab, whereas no significant influence was found at 0.1 µM and 10 µM Cetuximab or after 24 hours of incubation.

Figure 3. MTT-assay for FaDu cell line. Time points were 24 hours (A), 48 hours (B) and 72 hours (C). At 48 and 72 hours, ZnO-NPs increased tumor cell survival at 1 µM Cetuximab, whereas no significant influence was found at 0.1 µM and 10 µM Cetuximab or after 24 hours of incubation.

Figure 4. MTT-assay for HLaC cell line. Time points were 24 hours (A), 48 hours (B) and 72 hours (C). At 72 hours, ZnO-NPs increased tumor cell survival at 1 µM Cetuximab, whereas no significant influence was found at 0.1 µM and 10 µM Cetuximab or after 24 and 48 hours of incubation.

Figure 4. MTT-assay for HLaC cell line. Time points were 24 hours (A), 48 hours (B) and 72 hours (C). At 72 hours, ZnO-NPs increased tumor cell survival at 1 µM Cetuximab, whereas no significant influence was found at 0.1 µM and 10 µM Cetuximab or after 24 and 48 hours of incubation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.